Nurtec Odt

Active Ingredient(s): Rimegepant Sulfate
FDA Approved: * February 27, 2020
Pharm Company: * BIOHAVEN PHARM
Category: Migraine / Tension Headache

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Nurtec Odt Overview

Rimegepant (marketed as Nurtec ODT in the United States) is a medication for the treatment of an acute migraine with or without aura in adults.[1] It is not used prophylactically. [2] Taken by mouth to dissolve on or under the tongue,[2] rimegepant takes effect within an hour and can provide relief for up to 48 hours. It is not a narcotic and has no addictive potential; thus it is not designated as a controlled substance. It works by blocking CG...

Read more Nurtec Odt Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rimegepant

Recent Nurtec Odt Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Rimegepant Sulfate
  • Tablet, Orally Disintegrating: 75mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nurtec Odt: (1 result)

Sorted by National Drug Code
  • 72618-3000 Nurtec Odt 75 mg/75mg Oral Tablet, Orally Disintegrating by Biohaven Pharmaceuticals, Inc

Other drugs which contain Rimegepant Sulfate or a similar ingredient: (1 result)

Related Nurtec Odt Topics:

hyoscyamine odt
letter E onone side 423 on other side ## The pill in description is Hyoscyamine sulfate (0.125 mg). Hyoscyamine is used ... 2 replies




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 5 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA